Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: Findings from the KYSS study

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1045-1049

  Horiuchi, Takahiko ^a   Washio, Masakazu ^b   Kiyohara, Chikako ^a   Tsukamoto, Hiroshi ^a   Tada, Yoshifumi ^c   Asami, Toyoko ^d   Ide, Saburo ^b   Kobashi, Gen ^e   Takahashi, Hiroki ^f  

^a KYUSHU UNIVERSITY   (Japan)

^b ST MARY S COLLEGE   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d SAGA UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^f SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Combination; CYP1A1; GSTM1; Polymorphism; Reactive oxygen species; TNF RII

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RECEPTOR 2; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE;

ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; NULL ALLELE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; RISK FACTOR;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS;

EID: 70349782998     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep166     Document Type: Article

References (30)

1. Tsao Bp. Update on human systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:513-21.
2. Miyagawa H, Yamai M, Sakaguchi D et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology 2008;47:158-64.
3. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714-24.
4. Vandenabeele P, Declerq W, Beyaert R, Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 1995;5:392-9.
5. Studnicka-Benke A, Steine G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
6. Horiuchi T, Kiyohara C, Tsukamoto H et al. A functional M196R polymorphism of tumor necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis. Ann Rheum Dis 2007;66:320-4.
7. Morita C, Horiuchi T, Tsukamoto H et al. Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese. Molecular and functional analysis. Arthritis Rheum 2001;44:2819-27.
8. Costenbader KH, Kim DJ, Peerzada J et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004;50:849-57.
9. Washio M, Horiuchi T, Kiyohara C et al. Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females: findings from the KYSS study. Mod Rheumatol 2006;16:143-50.
10. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogeneous signaling pathways and environmental carcinogens. Nat Rev Cancer 2006;6:947-60.
11. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Ann Rev Pharmacol Toxicol 2005;45:51-88.
12. Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 2005;161:901-15.
13. Castelao JE, Yuan JM, Skipper PL et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-45.
14. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-9.
15. Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmune Rev 2008;7:544-9.
16. Fraser PA, Ding W-Z, Mohseni M et al. Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environmental interaction for autoimmunity. J Rheumatol 2003;30:276-82.
17. Yen J-H, Chen C-J, Tsai W-C et al. Cytochrome P450 and manganese superoxide dismutase genes polymorphisms in systemic lupus erythematosus. Immunol Lett 2003;90:19-24.
18. Knag T-Y, El-Sohemy A, Cornelis MC, Eny KM, Bae S-C. Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans. Lupus 2005;14: 381-4.
19. Karlson EW, Watts J, Signorovitch J et al. Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis. Arthritis Rheum 2007;56:244-54.
20. von Schmiedeberg S, Fritsche E, Ronnau AC et al. Polymorphisms of the xenobioticmetabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol 1999;455:147-52.
21. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Hochberg MC. for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
23. Horiuchi T, Tsukamoto H, Mitoma H et al. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int J Mol Med 2004;14:813-18.
24. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem (Tokyo) 1991;110:407-11.
25. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-4.
26. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 2001;44:1122-6.
27. Yen J-H, Chen C-J, Tsai W-C et al. Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan. Hum Immunol 2003;64:366-73.
28. Landi MT, Bertazzi PA, Shields PG et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994;4:242-6.
29. Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996;87:18-24.
30. Garg AK, Aggarwal BB. Reactive oxygen intermediates in TNF signaling. Mol Immunol 2002;39:509-17.